|
1
|
Studer D, Millan C, Öztürk E,
Maniura-Weber K and Zenobi-Wong M: Molecular and biophysical
mechanisms regulating hypertrophic differentiation in chondrocytes
and mesenchymal stem cells. Eur Cell Mater. 24:118–135.
2012.PubMed/NCBI
|
|
2
|
Eyre D: Collagen cross-linking amino
acids. Methods Enzymol. 144:115–139. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kempson GE, Muir H, Pollard C and Tuke M:
The tensile properties of the cartilage of human femoral condyles
related to the content of collagen and glycosaminoglycans. Biochim
Biophys Acta. 297:456–472. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hohenester E, Sasaki T, Giudici C,
Farndale RW and Bächinger HP: Structural basis of sequence-specific
collagen recognition by SPARC. Proc Natl Acad Sci USA.
105:18273–18277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Muehleman C, Bareither D, Huch K, Cole AA
and Kuettner KE: Prevalence of degenerative morphological changes
in the joints of the lower extremity. Osteoarthritis and Cartilage.
5:23–37. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mankin HJ and Buckwalter JA: Restoration
of the osteoarthrotic joint. J Bone Joint Surg Am. 78:1–2.
1996.
|
|
7
|
Nelson F, Dahlberg L, Laverty S, et al:
Evidence for altered synthesis of type II collagen in patients with
osteoarthritis. J Clin Invest. 102:2115–2125. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heathfield TF, Onnerfjord P, Dahlberg L
and Heinegård D: Cleavage of fibromodulin in cartilage explants
involves removal of the N-terminal tyrosine sulfate-rich region by
proteolysis at a site that is sensitive to matrix
metalloproteinase-13. J Biol Chem. 279:6286–6295. 2004. View Article : Google Scholar
|
|
9
|
Goldring MB and Goldring SR:
Osteoarthritis. J Cell Physiol. 213:626–634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Little CB, Hughes CE, Curtis CL, et al:
Matrix metalloproteinases are involved in C-terminal and
interglobular domain processing of cartilage aggrecan in late stage
cartilage degradation. Matrix Biology. 21:271–288. 2002. View Article : Google Scholar
|
|
11
|
Billinghurst RC, Dahlberg L, Ionescu M, et
al: Enhanced cleavage of type II collagen by collagenases in
osteoarthritic articular cartilage. J Clin Invest. 99:1534–1545.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dahlberg L, Billinghurst RC, Manner P, et
al: Selective enhancement of collagenase-mediated cleavage of
resident type II collagen in cultured osteoarthritic cartilage and
arrest with a synthetic inhibitor that spares collagenase 1 (matrix
metalloproteinase 1). Arthritis Rheum. 43:673–682. 2000. View Article : Google Scholar
|
|
13
|
Billinghurst RC, Wu W, Ionescu M, et al:
Comparison of the degradation of type II collagen and proteoglycan
in nasal and articular cartilages induced by interleukin-1 and the
selective inhibition of type II collagen cleavage by collagenase.
Arthritis Rheum. 43:664–672. 2000. View Article : Google Scholar
|
|
14
|
Tchetina EV, Kobayashi M, Yasuda T, et al:
Chondrocyte hypertrophy can be induced by a cryptic sequence of
type II collagen and is accompanied by the induction of MMP-13 and
collagenase activity: implications for development and arthritis.
Matrix Biology. 26:247–258. 2007. View Article : Google Scholar
|
|
15
|
Rolauffs B, Williams JM, Aurich M, et al:
Proliferative remodeling of the spatial organization of human
superficial chondrocytes distant from focal early osteoarthritis.
Arthritis Rheum. 62:489–498. 2010.
|
|
16
|
Xie DL, Hui F, Meyers R and Homandberg GA:
Cartilage chondrolysis by fibronectin fragments is associated with
release of several proteinases: stromelysin plays a major role in
chondrolysis. Arch Biochem Biophys. 311:205–212. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yasuda T, Tchetina E, Ohsawa K, et al:
Peptides of type II collagen can induce the cleavage of type II
collagen and aggrecan in articular cartilage. Matrix Biol.
25:419–429. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu H, McKenna LA and Dean MF: An
N-terminal peptide from link protein can stimulate biosynthesis of
collagen by human articular cartilage. Arch Biochem Biophys.
378:116–122. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McKenna LA, Liu H, Sansom PA and Dean MF:
An N-terminal peptide from link protein stimulates proteoglycan
biosynthesis in human articular cartilage in vitro. Arthritis
Rheum. 41:157–162. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schwartz Z, Carney DH, Crowther RS, Ryaby
JT and Boyan BD: Thrombin peptide (TP508) treatment of rat growth
plate cartilage cells promotes proliferation and retention of the
chondrocytic phenotype while blocking terminal endochondral
differentiation. J Cell Physiol. 202:336–343. 2005. View Article : Google Scholar
|
|
21
|
Homandberg GA, Ding L and Guo D:
Extracellular matrix fragments as regulators of cartilage
metabolism in health and disease. Curr Rheumatol Rev. 3:183–196.
2007. View Article : Google Scholar
|
|
22
|
Lorenzo P, Bayliss MT and Heinegård D:
Altered patterns and synthesis of extracellular matrix
macromolecules in early osteoarthritis. Matrix Biol. 23:381–391.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vogel WF, Abdulhussein R and Ford CE:
Sensing extracellular matrix: an update on discoidin domain
receptor function. Cell Signal. 18:1108–1116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu L, Peng H, Glasson S, et al: Increased
expression of the collagen receptor discoidin domain receptor 2 in
articular cartilage as a key event in the pathogenesis of
osteoarthritis. Arthritis Rheum. 56:2663–2673. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jennings L, Wu L, King KB, et al: The
effects of collagen fragments on the extracellular matrix
metabolism of bovine and human chondrocytes. Connect Tissue Res.
42:71–86. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu L, Polur I, Servais JM, et al: Intact
pericellular matrix of articular cartilage is required for
unactivated discoidin domain receptor 2 in the mouse model. Am J
Pathol. 179:1338–1346. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mankin HJ, Dorfman H, Lippiello L and
Zarins A: Biochemical and metabolic abnormalities in articular
cartilage from osteoarthritic human hips. II Correlation of
morphology with biochemical and metabolic data. J Bone Joint Surg
Am. 53:523–537. 1971.PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
29
|
He B, Lu N and Zhou Z: Cellular and
nuclear degradation during apoptosis. Curr Opin Cell Biol.
21:900–912. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Poole AR: What type of cartilage repair
are we attempting to attain? J Bone Joint Surg Am. 85A(Suppl 2):
40–44. 2003.
|
|
31
|
Aigner T and McKenna L: Molecular
pathology and pathobiology of osteoarthritic cartilage. Cell Mol
Life Sci. 59:5–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aigner T, Hemmel M, Neureiter D, et al:
Apoptotic cell death is not a widespread phenomenon in normal aging
and osteoarthritis human articular knee cartilage: a study of
proliferation, programmed cell death (apoptosis), and viability of
chondrocytes in normal and osteoarthritic human knee cartilage.
Arthritis Rheum. 44:1304–1312. 2001.
|
|
33
|
Goggs R, Carter SD, Schulze-Tanzil G,
Shakibaei M and Mobasheri A: Apoptosis and the loss of chondrocyte
survival signals contribute toarticular cartilage degradation in
osteoarthritis. Vet J. 166:140–158. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tchetina EV, Squires G and Poole AR:
Increased type II collagen degradation and very early focal
cartilage degeneration is associated with upregulation of
chondrocyte differentiation related genes in early human articular
cartilage lesions. J Rheumatol. 32:876–886. 2005.
|
|
35
|
Aurich M, Squires GR, Reiner A, et al:
Differential matrix degradation and turnover in early cartilage
lesions of human knee and ankle joints. Arthritis Rheum.
52:112–119. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Little CB, Barai A, Burkhardt D, et al:
Matrix metalloproteinase 13-deficient mice are resistant to
osteoarthritic cartilage erosion but not chondrocyte hypertrophy or
osteophyte development. Arthritis Rheum. 60:3723–3733. 2009.
View Article : Google Scholar
|
